MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma

Autor: Nymoen, Dag Andre, Slipicevic, Ana, Holth, Arild, Emilsen, Elisabeth, Hetland Falkenthal, Thea E., Tropé, Claes G., Reich, Reuven, Flørenes, Vivi Ann, Davidson, Ben
Zdroj: In Human Pathology August 2016 54:74-81
Databáze: ScienceDirect